PLYX — Polaryx Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Northern Trust, UnitedHealth, Tractor Supply
U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI
Polaryx rises after FDA grants fast-track status for rare disease drug
Brief: Polaryx Therapeutics Receives U.S. FDA Fast Track Designations For All Four Indications To Be Evaluated In The Soteria Basket Trial
Brief: Polaryx Therapeutics Receives FDA Fast Track Designation For Plx‑200 For Late‑Infantile Neuronal Ceroid Lipofuscinosis (Cln2 Disease)
NASDAQ RESUMED AT 11:12 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:07 AM
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM
Brief: Polaryx Therapeutics Selects Contract Research Organization For Soteria Phase 2 Basket Trial
NASDAQ RESUMED AT 10:27 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:20 AM
NASDAQ RESUMED AT 10:10 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM
NASDAQ RESUMED AT 10:19 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
NASDAQ RESUMED AT 10:13 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 03:34 PM